Analysis of ¹¹C-methionine Uptake in Low-Grade Gliomas and Correlation with Proliferative Activity

References

1. ↵
   Herholz K, Coope D, Jackson A. Metabolic and molecular imaging in neuro-oncology. Lancet Neurol 2007;6:711–24

   CrossRefPubMedWeb of Science
2. ↵
   van den Bent MJ, Afra D, de Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial. Lancet 2005;366:985–90

   CrossRefPubMedWeb of Science
3. ↵
   Stege EM, Kros JM, de Bruin HG, et al. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine. Cancer 2005;103:802–09

   CrossRefPubMedWeb of Science
4. ↵
   Whittle IR. The dilemma of low grade glioma. J Neurol Neurosurg Psychiatry 2004;75 Suppl 2:ii31–36
5. ↵
   Wessels PH, Weber WE, Raven G, et al. Supratentorial grade II astrocytoma: Biological features and clinical course. Lancet Neurol 2003;2:395–403

   CrossRefPubMedWeb of Science
6. ↵
   Goldman S, Wikler D, Damhaut P, et al. Positron emission tomography and brain tumours. Acta Neurol Belg 1997;97:183–86

   PubMed
7. ↵
   Di Chiro G, DeLaPaz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323–29

   Abstract/FREE Full Text
8. Ogawa T, Inugami A, Hatazawa J, et al. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine. AJNR Am J Neuroradiol 1996;17:345–53

   Abstract
9. Delbeke D, Meyerowitz C, Lapidus RL, et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995;195:47–52

   PubMed
10. ↵
    Kaschten B, Stevenaert A, Sadzot B, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998;39:778–85

    Abstract/FREE Full Text
11. ↵
    Bustany P, Chatel M, Derlon JM, et al. Brain tumor protein synthesis and histological grades: a study by positron emission tomography (PET) with C11-L-methionine. J Neurooncol 1986;3:397–404

    CrossRefPubMed
12. ↵
    Derlon JM, Bourdet C, Bustany P, et al. [11C]L-methionine uptake in gliomas. Neurosurgery 1989;25:720–28

    CrossRefPubMedWeb of Science
13. ↵
    Herholz K, Holzer T, Bauer B, et al. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998;50:1316–22

    Abstract/FREE Full Text
14. ↵
    De Witte O, Goldberg I, Wikler D, et al. Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 2001;95:746–50

    CrossRefPubMedWeb of Science
15. ↵
    Kim S, Chung JK, Im SH, et al. 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging 2005;32:52–59

    CrossRefPubMed
16. Sato N, Suzuki M, Kuwata N, et al. Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev 1999;22:210–14

    CrossRefPubMed
17. ↵
    Ribom D, Eriksson A, Hartman M, et al. Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer 2001;92:1541–49

    CrossRefPubMed
18. ↵
    Kracht LW, Friese M, Herholz K, et al. Methyl-[11C]-L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003;30:868–73

    CrossRefPubMed
19. ↵
    Smits A, Westerberg E, Ribom D. Adding (11)C-methionine PET to the EORTC prognostic factors in grade 2 gliomas. Eur J Nucl Med Mol Imaging 2008;35:65–71

    CrossRefPubMed
20. ↵
    Louis DN, Ohgaki H, Wiestler OD, et al. WHO classification of tumours of the central nervous system (2007). Lyon, France: IARC2007
21. ↵
    Miwa K, Shinoda J, Yano H, et al. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study. J Neurol Neurosurg Psychiatry 2004;75:1457–62

    Abstract/FREE Full Text
22. ↵
    Derlon JM, Petit-Taboué MC, Chapon F, et al. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine. Neurosurgery 1997;40:276–87; discussion 287–88

    CrossRefPubMedWeb of Science
23. ↵
    Cha S, Tihan T, Crawford F, et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005;26:266–73

    Abstract/FREE Full Text
24. ↵
    Vertosick FT Jr, Selker RG, Arena VC. Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography. Neurosurgery 1991;28:496–501

    CrossRefPubMedWeb of Science
25. ↵
    McCormack BM, Miller DC, Budzilovich GN, et al. Treatment and survival of low-grade astrocytoma in adults–1977–1988. Neurosurgery 1992;31:636–42; discussion 642

    CrossRefPubMedWeb of Science
26. ↵
    Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol. 1999;1:44–51

    Abstract/FREE Full Text
27. ↵
    Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 2007;170:1445–53

    CrossRefPubMedWeb of Science
28. ↵
    Langen KJ, Mühlensiepen H, Holschbach M, et al. Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. J Nucl Med 2000;41:1250–55

    Abstract/FREE Full Text
29. ↵
    Bergstrom M, Ericson K, Hagenfeldt L, et al. PET study of methionine accumulation in glioma and normal brain tissue: competition with branched chain amino acids. J Comput Assist Tomogr 1987;11:208–13

    PubMed
30. Killian DM, Chikhale PJ. Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature. Neurosci Lett 2001;306:1–4

    CrossRefPubMedWeb of Science
31. ↵
    Miyagawa T, Oku T, Uehara H, et al. “Facilitated” amino acid transport is upregulated in brain tumors J Cereb Blood Flow Metab 1998;18:500–09

    CrossRefPubMed
32. ↵
    Roelcke U, Radü E, Ametamey S, et al. Association of rubidium and C-methionine uptake in brain tumors measured by positron emission tomography. J Neurooncol 1996;27:163–71

    PubMed